Medical devices development brings its own regulatory complexity, evolving guidance, global variation, and heightened scrutiny around clinical evidence and post‑market surveillance.
Our specialist writers understand the interplay between clinical evidence, risk management, and post‑market obligations, helping teams navigate regulatory requirements without unnecessary complexity.
We apply the same principles across all medical device work: clarity, traceability, and consistency, supported by documented processes that stand up to inspection.
Morula Health delivers specialist medical writing for medical device and IVD companies, supporting EU MDR, IVDR, and FDA‑aligned submissions. Our team develops CERs, CEPs, PMCF documentation, and clinical investigation content, ensuring regulatory‑ready documentation grounded in device‑specific clinical evidence.
→ Clinical Evaluation Plans & Reports
→ Clinical Literature Reviews
→ Post‑Market Surveillance & PSURs
→ Summaries of Safety and Clinical Performance
→ Clinical Investigation Plans & Reports
→ Investigator’s Brochures & Informed Consent Forms
✔ Documentation built to withstand regulatory and audit scrutiny
✔ Clear linkage between clinical evidence and conclusions
✔ Reduced rework during review and assessment
How Morula Health saved a US biotech time and resources on a complex Phase 2 CSR
Morula Health supported a US biotech with the delivery of a complex Phase 2 Clinical Study Report. Our specialist clinical writers applied therapeutic and document‑level expertise to meet tight timelines while maintaining clarity, accuracy, and regulatory alignment.
Find out more
Navigating Regulatory And Medical Writing Challenges In MedTech
Find out more
Engage Patients And Create A Patient Centric Protocol With The Lean Startup
Find out more